Systematic review and cost effectiveness evaluation of a 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy
Martin Saborido C, Hockenhull J, Bagust A, Boland A, Dickson R, Todd D
Record ID 32010000252
English
Authors' recommendations:
Study found that a pill-in-the-pocket (PiP) strategy seems to be slightly less effective than antiarrhythmic drug therapy and in-hospital treatment but is associated with cost savings. A change in clinical practice that includes the introduction of PiP may save costs but also involves a reduction in clinical effectiveness compared to existing approaches used to treat patients with paroxysmal atrial fibrillation (PAF); however, there is insufficient evidence to support a recommendation for the use of PiP strategy in patients with PAF
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1944
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Anti-Arrhythmia Agents
- Propafenone
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2010 Queen’s Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.